APA (7th ed.) Citation

Gelfond, J., Al-Bayati, O., Kabra, A., Iffrig, K., Kaushik, D., & Liss, M. A. (2018). Modifiable risk factors to reduce renal cell carcinoma incidence: Insight from the PLCO trial. Urologic oncology, 36(7), 340.e1-340.e6. https://doi.org/10.1016/j.urolonc.2018.04.011

Chicago Style (17th ed.) Citation

Gelfond, Jonathan, Osamah Al-Bayati, Aashish Kabra, Kevan Iffrig, Dharam Kaushik, and Michael A. Liss. "Modifiable Risk Factors to Reduce Renal Cell Carcinoma Incidence: Insight from the PLCO Trial." Urologic Oncology 36, no. 7 (2018): 340.e1-340.e6. https://doi.org/10.1016/j.urolonc.2018.04.011.

MLA (9th ed.) Citation

Gelfond, Jonathan, et al. "Modifiable Risk Factors to Reduce Renal Cell Carcinoma Incidence: Insight from the PLCO Trial." Urologic Oncology, vol. 36, no. 7, 2018, pp. 340.e1-340.e6, https://doi.org/10.1016/j.urolonc.2018.04.011.